Digital Therapeutics Endometriosis Market Report 2026

Digital Therapeutics Endometriosis Market Overview

• Digital Therapeutics Endometriosis market size has reached to $1.7 billion in 2025 • Expected to grow to $4.65 billion in 2030 at a compound annual growth rate (CAGR) of 22.2% • Growth Driver: Rising Smartphone Adoption Driving Market Growth Through Enhanced Accessibility And Widespread User Engagement • Market Trend: Strategic Collaborations Driving Innovation And Enhanced Patient Support • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Digital Therapeutics Endometriosis Market?

Digital therapeutics endometriosis refers to clinically proven digital health interventions that use technology and data-driven approaches to help manage the condition effectively. These therapeutics are developed using scientific research and behavioral science principles to offer personalized, evidence-based treatment programs. They aim to address the physical, emotional, and lifestyle challenges associated with endometriosis while adhering to regulatory standards for safety and clinical effectiveness. The main product types of digital therapeutics endometriosis include software, devices, and services. Software refers to digital programs, platforms, and mobile applications that are designed to deliver therapeutic interventions and healthcare management solutions. It offers various deployment modes, such as on-premises and cloud-based, and is applied for pain management, symptom tracking, fertility management, education and awareness, and others. It is used by several end users, including hospitals and clinics, homecare, research institutes, and others.

What Is The Digital Therapeutics Endometriosis Market Growth Forecast?

The digital therapeutics endometriosis market size is expected to see exponential growth in the next few years. It will grow to $4.65 billion in 2030 at a compound annual growth rate (CAGR) of 22.2%. The growth in the forecast period can be attributed to increasing clinical validation of digital endometriosis therapies, rising demand for long-term condition management tools, expansion of cloud-based digital health platforms, growing integration with wearable health devices, increasing payer and provider adoption. Major trends in the forecast period include increasing adoption of personalized digital treatment programs, growing use of symptom and fertility tracking applications, expansion of behavior-based therapy platforms, rising integration of remote care and teleconsultation tools, enhanced focus on patient education and engagement.

Global Digital Therapeutics Endometriosis Market Segmentation

1) By Product Type: Software, Devices, Services 2) By Deployment Mode: On-Premises, Cloud-Based 3) By Application: Pain Management, Symptom Tracking, Fertility Management, Education And Awareness, Other Applications 4) By End User: Hospitals And Clinics, Homecare, Research Institutes, Other End Users Subsegments: 1) By Software: Mobile Applications, Web-Based Platforms, Cloud-Based Solutions, Decision Support Tools 2) By Devices: Wearable Monitoring Devices, Smart Therapeutic Devices, Digital Diagnostic Tools, Connected Medical Devices 3) By Services: Remote Patient Monitoring Services, Teleconsultation Services, Therapy Management Services, Data Analytics And Support Services

What Is The Driver Of The Digital Therapeutics Endometriosis Market?

The rapid adoption of smartphones is expected to propel the growth of the digital therapeutics endometriosis market going forward. Smartphones are handheld devices that integrate communication, internet access, and computing functions into a single device. Smartphones are rising due to increasing internet penetration, which allows more people to access online services, social media, and digital entertainment conveniently from their devices. Widespread smartphone adoption supports digital therapeutics endometriosis by providing users with easy and continuous access to personalized therapeutic apps, enabling real-time symptom tracking, data monitoring, and evidence-based treatment guidance anytime and anywhere. For instance, in February 2023, according to a report published by Uswitch Limited, a UK-based online and telephone comparison and switching service provider, there were 71.8 million active mobile connections in 2022, and by 2025, it is expected that 95% of the 68.3 million people living in the UK will own smartphones. Therefore, the rapid adoption of smartphones is expected to propel the growth of the digital therapeutics endometriosis industry.

Key Players In The Global Digital Therapeutics Endometriosis Market

Major companies operating in the digital therapeutics endometriosis market are Bayer AG, Kissei Pharmaceutical Co. Ltd., Abbott Laboratories, Luna Endoscore, Chugai Pharmaceutical Co. Ltd., Sword health inc., Charli , Maven Clinic Co., Flo Health Inc., Hinge Health Inc., PrecisionLife Ltd., TiumBio, EpicentRx Inc., Syrona Health, Matilda Health Care, ELANZA Wellness Inc., iCareBetter Inc., Endocare Clinic Fz LLc, Herabiotech, Ziwig Biotech, Hera Biotech Inc.

Global Digital Therapeutics Endometriosis Market Trends and Insights

Major companies operating in the digital therapeutics endometriosis market are focusing on developing strategic collaborations, to help accelerate innovation by bringing together diverse perspectives and specialized skills. Collaborations are partnerships where multiple parties join forces to achieve shared objectives, combine resources, or utilize each other’s strengths. For instance, in March 2024, Endometriosis Australia, an Australia-based nationally accredited charity, partnered with CHARLI, an Australia-based digital health company, to introduce a transformative platform aimed at supporting thousands of Australians affected by endometriosis. The collaboration resulted in the development of an app created by medical and health experts in collaboration with consumers. It uses AI to help women monitor menstruation, fertility, sexual health, pregnancy, and peri/menopause. The app also aids in detecting pain or potential conditions such as endometriosis. Partnering with Endometriosis Australia, it provides support to the one in seven Australians affected by the condition, enabling quicker diagnosis and easier access to care.

What Are Latest Mergers And Acquisitions In The Digital Therapeutics Endometriosis Market?

In March 2023, Chugai Pharmaceutical Co. Ltd., a Japan-based research and development-oriented pharmaceutical company, partnered with Biofourmis to focus on data-driven virtual care for endometriosis-related pain. Through this partnership, Chugai Pharmaceutical and Biofourmis aim to develop and implement digital therapeutics that objectively measure and manage pain in patients with endometriosis, improving treatment outcomes and quality of life. Biofourmis is a US-based digital therapeutics company that develop a digital solution for assessing and managing pain related to endometriosis.

Regional Insights

North America was the largest region in the digital therapeutics endometriosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Digital Therapeutics Endometriosis Market?

The digital therapeutics endometriosis market consists of revenues earned by entities by providing services such as personalized treatment programs, hormonal health management, teleconsultation support, and mental health support. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital therapeutics endometriosis market also includes sales of smart ring monitors, implantable sensor devices, wireless hormone monitoring biosensor, and wearable sleep tracker. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Digital Therapeutics Endometriosis Market Report 2026?

The digital therapeutics endometriosis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the digital therapeutics endometriosis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.